1. 1239TiPMORPHEUS: A phase Ib/II umbrella study platform evaluating the safety and efficacy of multiple cancer immunotherapy (CIT)-based combinations in different tumour types. (23rd October 2018) Authors: Chau, I; Haag, G M; Rahma, O E; Macarulla, T M; McCune, S L; Yardley, D A; Solomon, B J; Johnson, M; Vidal, G A; Schmid, P; Argiles, G; Dimick, K; Mahrus, S; Abdullah, H; He, X; Sayyed, P; Barak, H; Bleul, C; Cha, E; Drakaki, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗